ADHD symptoms in neurometabolic diseases: Underlying mechanisms and clinical implications

  title={ADHD symptoms in neurometabolic diseases: Underlying mechanisms and clinical implications},
  author={Selina Cannon Homaei and Helene Barone and Rune Kleppe and Nibal Betari and Andreas Reif and Jan Haavik},
  journal={Neuroscience \& Biobehavioral Reviews},

Figures and Tables from this paper

Current Understanding on the Genetic Basis of Key Metabolic Disorders: A Review

The review focuses on fourteen of the most widely studied inherited MD, which are familial hypercholesterolemia, Gaucher disease, Hunter syndrome, Krabbe disease, Maple syrup urine disease, Metachromatic leukodystrophy, Mitochondrial encephalopathy lactic acidosis stroke-like episodes, Niemann-Pick disease, Phenylketonuria, Porphyria, Tay-Sachs disease, Wilson’s disease and Galactosemia.

Time Series Analyses of the Responses to Sensory Stimuli of Children with Severe and Multiple Disabilities

Severe and multiple disabilities (SMD) refers to the simultaneous occurrence of intellectual and physical problems. SMD in children is difficult to assess, as they often do not have the proper

Genome Guided Personalized Drug Therapy in Attention Deficit Hyperactivity Disorder

  • J. Haavik
  • Biology, Medicine
    Frontiers in Psychiatry
  • 2022
It is suggested that genome guided therapies could be introduced gradually, starting with rare ADHD syndromes with highly penetrant risk genes, starting in cases with suspected neurometabolic disorders.

Neurological Mechanisms of Diagnosis and Therapy in School Children with ADHD in Poland

The paper compares the concordance of a medical diagnosis confirming ADHD syndrome with the occurrence of abnormal electrical brain function recording and abnormalities therein as well as the effectiveness of the neurofeedback therapy to confirm that the reported problems faced by pupils and affecting their emotional functioning are reflected in their EEG records.

Effect of Bifidobacterium bifidum on Clinical Characteristics and Gut Microbiota in Attention-Deficit/Hyperactivity Disorder

The probiotics supplements using Bifidobacterium bifidum (Bf-688) can improve clinical characteristics and gut microbiomes among patients with attention-deficit/hyperactivity disorder (ADHD) and was associated with an improvement of clinical symptoms and with weight gain among ADHD children.



Psychiatric and Cognitive Aspects of Phenylketonuria: The Limitations of Diet and Promise of New Treatments

Dietary treatment, particularly when maintained across neurodevelopment and well into adulthood, has resulted in markedly improved outcomes at a cognitive and psychiatric level for individuals with PKU, but few individuals can maintain full dietary control lifelong, and an elevated risk remains of mood, anxiety, and attentional disorders across the lifespan.

Brain branched-chain amino acids

  • 2020

Tyrosinemia Type 1 and symptoms of ADHD: Biochemical mechanisms and implications for treatment and prognosis

  • Helene BaroneY. Bliksrud J. Haavik
  • Biology
    American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
  • 2019
The results support recommendations of strict guidelines on plasma tyrosine levels in HT‐1 and suggest ADHD‐related deficits, particularly inattention, should be monitored inHT‐1 patients to determine whether intervention is necessary.

Adult ADHD and Comorbid Somatic Disease: A Systematic Literature Review

There are few large systematic studies using standardized diagnostic criteria evaluating adult ADHD and somatic comorbidities, and significant associations are found betweenadult ADHD and several somatic diseases.

Age‐related phenotype and biomarker changes in SSADH deficiency

Succinic Semialdehyde Dehydrogenase deficiency is a disorder of elevated gamma‐amino butyric acid and gamma hydroxybutyric acid with a complex neuropsychiatric profile.

Sanfilippo syndrome: Overall review

There is no global consensus for treatment, enzyme replacement therapy and gene therapy can provide appropriate results, but recent publications on treatment and follow-up are discussed.

Metabolomics as a Tool for Discovery of Biomarkers of Autism Spectrum Disorder in the Blood Plasma of Children

Analysis of blood plasma metabolites resulted in the discovery of biomarkers that may be valuable in the diagnosis of young children with ASD, and will form the basis for additional discovery and validation research.